MoneyWorks4Me

Nath Bio-Genes reports Profit after tax of Rs 307.56 Mln, in the June 2022 quarter

16 Aug 2022 Evaluate
Revenue showed a marginal decline at Rs. 2093.90 millions. For the quarter ended June 2022, as compared to corresponding quarter of last year.The Company to register a -31.52%  fall in the net profit for the quarter ended June 2022.The Operating Profit of the company witnessed a decrease to 344.80 millions from 485.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2093.90 2151.03 -2.66 2093.90 2151.03 -2.66 2802.17 3092.31 -9.38
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 344.80 485.30 -28.95 344.80 485.30 -28.95 390.91 683.86 -42.84
Interest 28.83 26.57 8.51 28.83 26.57 8.51 106.11 88.19 20.32
PBDT 315.97 458.73 -31.12 315.97 458.73 -31.12 -603.02 595.67 -201.23
Depreciation 6.74 6.77 -0.44 6.74 6.77 -0.44 30.84 28.16 9.52
PBT 309.23 451.96 -31.58 309.23 451.96 -31.58 -633.86 567.51 -211.69
TAX 1.67 2.85 -41.40 1.67 2.85 -41.40 39.51 10.90 262.48
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 16.11 6.94 132.13
PAT 307.56 449.11 -31.52 307.56 449.11 -31.52 -673.37 556.61 -220.98
Equity 190.04 190.04 0.00 190.04 190.04 0.00 190.04 190.04 0.00
PBIDTM(%) 16.47 22.56 -27.01 16.47 22.56 -27.01 13.95 22.11 -36.92
Peers